Advisornet Financial’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-200
Closed -$16.1K 2201
2024
Q2
$16.1K Sell
200
-3
-1% -$274 ﹤0.01% 1170
2024
Q1
$18.7K Buy
+203
New +$19.5K ﹤0.01% 1091
2023
Q2
Sell
-5
Closed -$623 2362
2023
Q1
$623 Hold
5
﹤0.01% 2009
2022
Q4
$751 Hold
5
﹤0.01% 1911
2022
Q3
$1K Sell
5
-7
-58% -$1.07K ﹤0.01% 1740
2022
Q2
$2K Hold
12
﹤0.01% 1671
2022
Q1
$2K Hold
12
﹤0.01% 1764
2021
Q4
$3K Buy
12
+7
+140% +$1.92K ﹤0.01% 1729
2021
Q3
$1K Buy
+5
New +$1.59K ﹤0.01% 1801

Other funds holding BNTX

Advisornet Financial's BNTX Position: Q3 2024 in Review

Advisornet Financial sold out of BioNTech (BNTX) in Q3 2024, closing a stake of 200 shares — an estimated $16.1K sold.

Advisornet Financial first reported a position in BNTX in Q3 2021 and held it in 9 quarters. The position peaked at $18.7K in Q1 2024. 296 funds tracked by Wall St. Rank hold BNTX as of Q3 2024.

  • Advisornet Financial reported no remaining BioNTech position as of Q3 2024 after selling out during the quarter.
  • Advisornet Financial sold 200 BioNTech shares in Q3 2024, an estimated $16.1K.
  • Advisornet Financial first reported a position in BioNTech in Q3 2021 and held it in 9 quarters.
  • Advisornet Financial's BioNTech position peaked at $18.7K in Q1 2024.
  • 296 funds tracked by Wall St. Rank held BioNTech as of Q3 2024.

Based on Advisornet Financial's 13F filing for Q3 2024, filed 15 Oct 2024.